Harmit S. Kalia

发表

Hepatitis B virus and renal transplantation.

F. Fabrizi, Paul L. Martin, Harmit S. Kalia, 2011, Transplantation reviews.

The Prevalence and Pathobiology of Nonalcoholic Fatty Liver Disease in Patients of Different Races or Ethnicities.

P. Gaglio, Harmit S. Kalia, 2016, Clinics in liver disease.

Nodular Regenerative Hyperplasia

A. Akki, M. Izzy, Kathryn E. Tanaka, 2017, Journal of investigative medicine high impact case reports.

Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications

Sooah Kim, N. Theise, James S. Park, 2021, The American journal of gastroenterology.

Novel therapies and potential therapeutic targets in the management of chronic hepatitis B

M. Izzy, Harmit S. Kalia, J. Serigado, 2017, European journal of gastroenterology & hepatology.

Treatment of HCV in patients with renal failure.

Paul L. Martin, P. M. Lopez, Harmit S. Kalia, 2007, Archives of medical research.

Antiretroviral Medications Associated With Nodular Regenerative Hyperplasia . Medication Name Class Didanosine Nucleoside reverse transcriptase inhibitor Zidovudine Nucleoside reverse transcriptase inhibitor Stavudine Nucleoside reverse transcriptase inhibitor Tenofovir Nucleotide reverse transcript

A. Akki, M. Izzy, Kathryn E. Tanaka, 2017 .

Preservation of myocardial microcirculation during mechanical reperfusion for myocardial ischemia with either abciximab or eptifibatide.

J. Skurnick, M. Saric, R. Arora, 2003, The Journal of invasive cardiology.

Genetic analysis of nonalcoholic fatty liver disease within a Caribbean–Hispanic population

A. Auton, B. Morrow, A. Wolkoff, 2015, Molecular genetics & genomic medicine.

Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections

R. Montgomery, B. Lonze, T. Lewis, 2021, Transplantation direct.

A hospitalist’s approach to managing acute kidney injury (hepatorenal syndrome) in cirrhosis

Harmit S. Kalia, Alexa Giammarino, 2024, Clinical Liver Disease.